Asia Morning Update

US stocks saw some light in the early part of the session, only to be let down once again by the delay in the healthcare reform bill vote.

Source: Bloomberg

Interestingly the vote has just been postponed to Friday, which could keep markets on the edge of their seats.

A mild red was seen on the comprehensive S&P 500 index on Thursday, with relatively moderate movements across most sectors. Sentiment appears to have been a significant driver for post-election rally. The vacuum of leads from both the Federal Reserve and the highly anticipated pro-growth policies had probably awarded the healthcare reform bill vote pronounced importance in influencing trade. Certainly, the postponing of the event had reinforced some concern from the markets on the new administration’s ability to push through with their policies. The quick determination of the vote date however suggests that the results remain to be seen though the Trump administration do appear confident enough to move things with such urgency.

Thursday also saw the financial sector rising 0.22% after four consecutive sessions of losses though we have seen little coming from Fed members overnight. Federal Reserve chair Janet Yellen had avoided talks on monetary policy and economic conditions altogether, exercising little sway upon the markets. Notably however, Dallas Fed President Robert Kaplan’s comments this morning focused on stronger economic conditions, urging the Fed in ‘removing accommodation’. This has seen the USD index pick up slightly, and the USD/JPY up slightly from the $111.00 trade overnight.

Perhaps a proxy for Asia, the meeting between the leaders of China and Australia appear to have injected positive sentiment for the region. The ASX 200 was up more than 1.0% when last checked at 8.30am (Singapore time) with broad gains across sectors. The Nikkei 225 meanwhile continued to reverse losses this morning, up 0.4%, underpinned by the USD/JPY movements as well. Asian markets are expected to see gains into the end of the week with US healthcare vote on the line.

The day ahead is expected to rival Thursday in the amount of items to keep watch for. Data expected from Asia includes Malaysia’s February inflation rate and Singapore’s February industrial production update. Other than the high-key healthcare vote in the US, we have February durable goods data and March Markit PMI data expected. St. Louis and New York Fed Presidents will also be on the wires today.

Yesterday: S&P 500 -0.11%; DJIA -0.02%; DAX +1.14%; FTSE +0.22%

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IG Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.